Genetic variation in COX-2 -1195 and the risk of endometriosis and adenomyosis
This study found that the G to A genetic variation at the COX-2 -1195 locus increases the risk for endometriosis and adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper studied whether COX-2 promoter polymorphism at the -1195 (G to A) locus is associated with hereditary susceptibility to endometriosis and adenomyosis. Using genotyping in 170 endometriosis cases, 150 adenomyosis cases, and 240 matched controls without either condition, the authors found that GG/AG/AA genotype frequencies in both endometriosis and adenomyosis groups differed significantly from controls (p < 0.05), with higher A allele frequencies in cases. Individuals carrying two A alleles had increased risk compared with non-A genotypes, with risk estimates of 2.19 for endometriosis and 2.41 for adenomyosis. The paper notes that genetic susceptibility appears similar across both conditions, but it does not describe any additional limitation such as replication or functional validation. This paper is centrally about endometriosis and adenomyosis—specifically the association between COX-2 -1195 (G/A) polymorphism and increased risk for both diseases.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,879 characters
· extracted from
oa-doi-fallback
· 2 sections
· click to expand
Abstract
Keywords
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters via openalex
- Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women via openalex
- CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women via openalex
- Estrogen receptor-alpha gene (T/C) Pvu II polymorphism in endometriosis and uterine fibroids. via openalex
- Functional genetic polymorphisms and female reproductive disorders: Part II--endometriosis via openalex
- Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis via openalex
- Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis via openalex
- Stretch magnitude- and frequency-dependent cyclooxygenase 2 and prostaglandin E2 up-regulation in human endometrial stromal cells: Possible implications in endometriosis via openalex
- What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis via openalex
- W2100258830 via openalex
- W2122189377 via openalex
- W4244784510 via openalex
- W6666702738 via openalex
- W1546894543 via openalex
- W6678182219 via openalex
- W1593019610 via openalex
- W1920274084 via openalex
- W1979439104 via openalex
- W2011342311 via openalex
- W2049019160 via openalex
- W2049352234 via openalex
- W2052572594 via openalex
- W2064632278 via openalex
Cited by (21)
- Characteristics of menstrual blood-derived stem cells from women with endometriosis: A systematic review 2026
- Proteomic detection of COX-2 pathway-related factors in patients with adenomyosis 2024
- Network pharmacology and experimental validation to explore the potential mechanism of Sanjie Zhentong Capsule in endometriosis treatment 2023
- Establishment of an immortalized cell line derived from human adenomyosis ectopic lesions 2023
- Immunohistochemical expression of Drosha is reduced in eutopic and ectopic endometrium of women with adenomyosis 2022
- Insights on Adenomyosis Development 2022
- Celecoxib reduces inflammation and angiogenesis in mice with adenomyosis. 2021
- Celecoxib, a selective COX‑2 inhibitor, markedly reduced the severity of tamoxifen‑induced adenomyosis in a murine model 2020
- Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- Adenomiosis. Una gran desconocida: ¿Qué debemos saber? 2020
- Epidemiological aspects of the outcomes from the treatment of endometriosis: Experience from two different geographical areas 2019
- Cyclooxygenase-2 in Endometriosis 2019
- A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update 2018
- Association of Endometriosis and Adenomyosis: Vast Literature but Scant Conclusive Data 2018
- Dysmenorrhea, endometriosis, adenomyosis: clinical and pathogenetic relationships 2018
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? 2018
- DYSMENORRHEA, ADENOMYOSIS, ENDOMETRIOSIS, TUMOR PROCESS: CAUSATION 2017
- MicroRNA-17 downregulates expression of the PTEN gene to promote the occurrence and development of adenomyosis 2017
- COMPLEX ASSESSMENT OF REPRODUCTIVE HEALTH IN PATIENTS WITH EXTERNAL GENITAL ENDOMETRIOSIS AFTER SURGERY 2016
- Hypoxia-inducible factor-1alpha: A promising therapeutic target in endometriosis 2016
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:17:52.213533+00:00